228 related articles for article (PubMed ID: 20669977)
1. Comparison of cyclooxygenase-1 crystal structures: cross-talk between monomers comprising cyclooxygenase-1 homodimers.
Sidhu RS; Lee JY; Yuan C; Smith WL
Biochemistry; 2010 Aug; 49(33):7069-79. PubMed ID: 20669977
[TBL] [Abstract][Full Text] [Related]
2. Coxibs interfere with the action of aspirin by binding tightly to one monomer of cyclooxygenase-1.
Rimon G; Sidhu RS; Lauver DA; Lee JY; Sharma NP; Yuan C; Frieler RA; Trievel RC; Lucchesi BR; Smith WL
Proc Natl Acad Sci U S A; 2010 Jan; 107(1):28-33. PubMed ID: 19955429
[TBL] [Abstract][Full Text] [Related]
3. Partnering between monomers of cyclooxygenase-2 homodimers.
Yuan C; Rieke CJ; Rimon G; Wingerd BA; Smith WL
Proc Natl Acad Sci U S A; 2006 Apr; 103(16):6142-7. PubMed ID: 16606823
[TBL] [Abstract][Full Text] [Related]
4. Interactions of fatty acids, nonsteroidal anti-inflammatory drugs, and coxibs with the catalytic and allosteric subunits of cyclooxygenases-1 and -2.
Smith WL; Malkowski MG
J Biol Chem; 2019 Feb; 294(5):1697-1705. PubMed ID: 30710016
[TBL] [Abstract][Full Text] [Related]
5. Cyclooxygenase Allosterism, Fatty Acid-mediated Cross-talk between Monomers of Cyclooxygenase Homodimers.
Yuan C; Sidhu RS; Kuklev DV; Kado Y; Wada M; Song I; Smith WL
J Biol Chem; 2009 Apr; 284(15):10046-55. PubMed ID: 19218248
[TBL] [Abstract][Full Text] [Related]
6. Molecular modelling of the differential interaction between several non-steroidal anti-inflammatory drugs and human prostaglandin endoperoxide H synthase-2 (h-PGHS-2).
Pouplana R; Lozano JJ; Ruiz J
J Mol Graph Model; 2002 Jan; 20(4):329-43. PubMed ID: 11858641
[TBL] [Abstract][Full Text] [Related]
7. The structure of mammalian cyclooxygenases.
Garavito RM; Mulichak AM
Annu Rev Biophys Biomol Struct; 2003; 32():183-206. PubMed ID: 12574066
[TBL] [Abstract][Full Text] [Related]
8. Pre-existent asymmetry in the human cyclooxygenase-2 sequence homodimer.
Dong L; Sharma NP; Jurban BJ; Smith WL
J Biol Chem; 2013 Oct; 288(40):28641-55. PubMed ID: 23955344
[TBL] [Abstract][Full Text] [Related]
9. Cyclooxygenase competitive inhibitors alter tyrosyl radical dynamics in prostaglandin H synthase-2.
Wu G; Tsai AL; Kulmacz RJ
Biochemistry; 2009 Dec; 48(50):11902-11. PubMed ID: 19894761
[TBL] [Abstract][Full Text] [Related]
10. The structural and electronical factors that contribute affinity for the time-dependent inhibition of PGHS-1 by indomethacin, diclofenac and fenamates.
Pouplana R; Pérez C; Sánchez J; Lozano JJ; Puig-Parellada P
J Comput Aided Mol Des; 1999 May; 13(3):297-313. PubMed ID: 10216835
[TBL] [Abstract][Full Text] [Related]
11. Structural basis of the dynamic mechanism of ligand binding to cyclooxygenase.
Llorens O; Perez JJ; Palomer A; Mauleon D
Bioorg Med Chem Lett; 1999 Oct; 9(19):2779-84. PubMed ID: 10522690
[TBL] [Abstract][Full Text] [Related]
12. Human cyclooxygenase-2 is a sequence homodimer that functions as a conformational heterodimer.
Dong L; Vecchio AJ; Sharma NP; Jurban BJ; Malkowski MG; Smith WL
J Biol Chem; 2011 May; 286(21):19035-46. PubMed ID: 21467029
[TBL] [Abstract][Full Text] [Related]
13. The interaction of arginine 106 of human prostaglandin G/H synthase-2 with inhibitors is not a universal component of inhibition mediated by nonsteroidal anti-inflammatory drugs.
Greig GM; Francis DA; Falgueyret JP; Ouellet M; Percival MD; Roy P; Bayly C; Mancini JA; O'Neill GP
Mol Pharmacol; 1997 Nov; 52(5):829-38. PubMed ID: 9351974
[TBL] [Abstract][Full Text] [Related]
14. Fatty Acid Binding to the Allosteric Subunit of Cyclooxygenase-2 Relieves a Tonic Inhibition of the Catalytic Subunit.
Dong L; Yuan C; Orlando BJ; Malkowski MG; Smith WL
J Biol Chem; 2016 Dec; 291(49):25641-25655. PubMed ID: 27756840
[TBL] [Abstract][Full Text] [Related]
15. Prostaglandin endoperoxide H synthases: peroxidase hydroperoxide specificity and cyclooxygenase activation.
Liu J; Seibold SA; Rieke CJ; Song I; Cukier RI; Smith WL
J Biol Chem; 2007 Jun; 282(25):18233-18244. PubMed ID: 17462992
[TBL] [Abstract][Full Text] [Related]
16. Structure-based QSAR study on differential inhibition of human prostaglandin endoperoxide H synthase-2 (COX-2) by nonsteroidal anti-inflammatory drugs.
Pouplana R; Lozano JJ; Pérez C; Ruiz J
J Comput Aided Mol Des; 2002 Oct; 16(10):683-709. PubMed ID: 12650588
[TBL] [Abstract][Full Text] [Related]
17. Cyclooxygenases: structural, cellular, and molecular biology.
Smith WL; DeWitt DL; Garavito RM
Annu Rev Biochem; 2000; 69():145-82. PubMed ID: 10966456
[TBL] [Abstract][Full Text] [Related]
18. Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents.
Kurumbail RG; Stevens AM; Gierse JK; McDonald JJ; Stegeman RA; Pak JY; Gildehaus D; Miyashiro JM; Penning TD; Seibert K; Isakson PC; Stallings WC
Nature; 1996 Dec 19-26; 384(6610):644-8. PubMed ID: 8967954
[TBL] [Abstract][Full Text] [Related]
19. The structure of NS-398 bound to cyclooxygenase-2.
Vecchio AJ; Malkowski MG
J Struct Biol; 2011 Nov; 176(2):254-8. PubMed ID: 21843643
[TBL] [Abstract][Full Text] [Related]
20. On the interaction of specific prostaglandin H synthase-2 inhibitors with prostaglandin H synthase-1.
Burde T; Rimon G
Eur J Pharmacol; 2002 Oct; 453(2-3):167-73. PubMed ID: 12398900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
